Search Results 221-230 of 13964 for Moderate acute malnutrition

1. Study Of MLN4924 Plus Azacitidine In Treatment-Naïve Patients With Acute Myelogenous Leukemia (AML) Who Are 60 Years Or Older - Mayo Clinic

   Known moderate to severe chronic obstructive pulmonary disease, interstitial lung disease, and pulmonary fibrosis; Body mass index > 40 kg/m²; Treatment with ...

2. A Study of Neurophysiological and Inflammatory Biomarkers of Seizures and Brain Injury in Children - Mayo Clinic

   Neonates with moderate to severe hypoxic ischemic encephalopathy admitted to the Mayo Clinic neonatal ICU; Children with altered mental status admitted to ...

3. A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients with Mild to Moderate Alzheimer's Disease - Mayo Clinic

   A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients with Mild to Moderate Alzheimer's Disease ... Severe or unstable medical condition that, in ...

4. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

   The purpose of this study is to evaluate the effectiveness and safety of MEDI2070 in subjects with moderate to severe crohn's disease who have failed or are ...

5. Recording Breath Acoustics and Lung Mechanics in Patients with COPD, Asthma, and Cystic Fibrosis - Mayo Clinic

   COPD (mild, moderate, severe); Asthma (mild, moderate, severe); Cystic fibrosis (mild, moderate, severe). Healthy subjects must: be 18 years of age or older ...

6. Short bowel syndrome - Symptoms and causes - Mayo Clinic

   Greasy, foul-smelling stools. Extreme tiredness. Weight loss. Not enough nutrition from foods, also called malnutrition. Slower growth and development than ...

7. Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension - Mayo Clinic

   Intrinsic (prolapse, rheumatic) valve disease with more than moderate mitral, tricuspid or aortic regurgitation. Acute or chronic severe liver disease as ...

8. A Study Of The Effectiveness Of LY3314814 In Patients With Mild Alzheimer's Disease Dementia - Mayo Clinic

   Participation eligibility · Myocardial infarction · Moderate or severe congestive heart failure · New York Heart Association class III or IV · Hospitalization for, ...

9. Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER - Mayo Clinic

   ... moderate or severe aortic valve stenosis. Since enrollment into Study MYK-461-004, has developed any acute or serious comorbid condition (eg, major ...

10. Breast MR - Mayo Clinic

    History of prior moderate or severe contrast reaction including unresponsiveness, severe respiratory distress, convulsions, arrhythmia, cardiopulmonary ...